We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $434M
1-Year Est. Return 19.64%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+19.64%
3 Year Est. Return
+41.56%
5 Year Est. Return
+34.45%
10 Year Est. Return
+261.65%
AUM
$434M
AUM Growth
-$28.5M
Cap. Flow
-$39M
Cap. Flow %
-8.97%
Top 10 Hldgs %
10.4%
Holding
334
New
66
Increased
40
Reduced
42
Closed
103

Top Buys

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$4.08M
2
UI icon
Ubiquiti
UI
+$3.96M
3
CRM icon
Salesforce
CRM
+$3.69M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.57M
5
GMED icon
Globus Medical
GMED
+$3.57M

Top Sells

Rank Stock Value
1
CORT icon
Corcept Therapeutics
CORT
+$5.08M
2
SEZL
Sezzle
SEZL
+$3.99M
3
PSIX
Power Solutions International
PSIX
+$3.84M
4
QLYS icon
Qualys
QLYS
+$3.69M
5
PGNY icon
Progyny
PGNY
+$3.57M

Sector Composition

Rank Sector Weight
1 Healthcare 23.08%
2 Technology 17.18%
3 Consumer Discretionary 15.3%
4 Financials 9.77%
5 Consumer Staples 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHAT icon
301
Phathom Pharmaceuticals
PHAT
$625M
– –
-84,000
Closed -$933K
PLMR icon
302
Palomar
PLMR
$3.6B
– –
-10,500
Closed -$1.25M
PLNT icon
303
Planet Fitness
PLNT
$3.77B
– –
-25,200
Closed -$1.87M
PRG icon
304
PROG Holdings
PRG
$1.44B
– –
-42,000
Closed -$1.2M
PTGX icon
305
Protagonist Therapeutics
PTGX
$9.3B
– –
-10,500
Closed -$1.11M
QGEN icon
306
Qiagen
QGEN
$9.11B
– –
-84,000
Closed -$3.36M
QLYS icon
307
Qualys
QLYS
$6.24B
– –
-42,000
Closed -$3.69M
RIVN icon
308
Rivian
RIVN
$23B
– –
-63,000
Closed -$948K
SBH icon
309
Sally Beauty Holdings
SBH
$1.48B
– –
-210,000
Closed -$2.91M
SBUX icon
310
Starbucks
SBUX
$111B
– –
-21,000
Closed -$1.88M
SEZL
311
Sezzle
SEZL
$3.89B
– –
-63,000
Closed -$3.99M
SIG icon
312
Signet Jewelers
SIG
$3.88B
– –
-31,500
Closed -$2.67M
SNEX icon
313
StoneX
SNEX
$8.08B
– –
-33,075
Closed -$1.78M
SPNT icon
314
SiriusPoint
SPNT
$2.84B
– –
-42,000
Closed -$905K
SPSC icon
315
SPS Commerce
SPSC
$2.89B
– –
-10,500
Closed -$585K
SVV icon
316
Savers
SVV
$1.43B
– –
-315,000
Closed -$2.34M
TIGO icon
317
Millicom
TIGO
$16.2B
– –
-16,800
Closed -$1.26M
TK icon
318
Teekay
TK
$1.3B
– –
-63,000
Closed -$769K
TMDX icon
319
Transmedics
TMDX
$3.01B
– –
-31,500
Closed -$3.13M
TNET icon
320
TriNet
TNET
$3.12B
– –
-21,000
Closed -$765K
TRV icon
321
Travelers Companies
TRV
$78.8B
– –
-4,200
Closed -$1.23M
TTD icon
322
Trade Desk
TTD
$6.72B
– –
-42,000
Closed -$953K
UPWK icon
323
Upwork
UPWK
$1.06B
– –
-210,000
Closed -$2.3M
VITL icon
324
Vital Farms
VITL
$471M
– –
-42,000
Closed -$593K
WING icon
325
Wingstop
WING
$2.81B
– –
-16,800
Closed -$2.6M
10 11 12
13
14

Similar funds

NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
DCM
Divisar Capital Management San Francisco, California $434M AUM 170.22% 1-Year Est. Return
SCP
Seafarer Capital Partners Larkspur, California $434M AUM 22.8% 1-Year Est. Return
NRC
New Republic Capital Charlotte, North Carolina $434M AUM 31.16% 1-Year Est. Return
CEI
Clark Estates Inc New York $434M AUM 15% 1-Year Est. Return
CFG
Carr Financial Group Worcester, Massachusetts $434M AUM 28.34% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $434M AUM 68.57% 1-Year Est. Return
OCPWS
One Charles Private Wealth Services Hingham, Massachusetts $434M AUM 22.37% 1-Year Est. Return

Hussman Strategic Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Hussman Strategic Advisors held 334 positions worth $434M, down 6.2% from $463M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Hussman Strategic Advisors withdrew a net $39M in Q2 2026, closing 103 positions and reducing 42 holdings. Its most notable exit was Corcept Therapeutics, an estimated $5.08M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Hussman Strategic Advisors opened a new position in Salesforce worth $3.29M.

  • Hussman Strategic Advisors's largest Q2 2026 buy was Salesforce: 21,000 shares worth $3.29M.
  • Hussman Strategic Advisors added most to PepsiCo in Q2 2026, an estimated $4.08M increase.
  • Hussman Strategic Advisors's biggest Q2 2026 reduction was Concentrix, cutting an estimated $2.74M.
  • Hussman Strategic Advisors fully exited Corcept Therapeutics in Q2 2026, selling an estimated $5.08M.
  • Hussman Strategic Advisors's ten largest holdings make up 10% of its $434M portfolio in Q2 2026.
  • Hussman Strategic Advisors opened 66 new positions and closed 103 in Q2 2026.
  • Hussman Strategic Advisors's portfolio value fell 6.2% quarter-over-quarter to $434M.

Based on Hussman Strategic Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.